Literature DB >> 17093121

Failed excitability of spinal motoneurons induced by prolonged running exercise.

S Racinais1, O Girard, J P Micallef, S Perrey.   

Abstract

The main purpose of this study was to investigate the modulations in H-reflex and V-wave responses (spinal loop properties) induced by prolonged locomotion activities. The second purpose was to compare the development of central fatigue between continuous and intermittent running modes. Eleven males randomly performed two 90-min running exercises either continuously (CONT, first ventilatory threshold) or intermittently (INT, 150 s at a velocity 20% higher than that during CONT/30 s of recovery). Neuromuscular tests of the plantar flexors [including M-wave and H-reflex at rest and M-wave and V-wave during maximal voluntary contraction (MVC)] were performed before and 5 and 30 min after the running exercises. During MVC, the torque significantly decreased (P < 0.05) from preexercise to 5 and 30 min postexercise (-11 and -9%, respectively), as did the RMS/M ratio (-11 and -13%, respectively) and the V/M ratio (-19 and -37%, respectively) for the soleus muscle. At rest, the H/M ratio also decreased significantly (P < 0.001) from preexercise to 5 and 30 min postexercise (-61 and -55%, respectively). Last, no difference in the alteration of spinal loop properties was noted between CONT and INT. In conclusion, the results regarding H-reflex and V-wave suggest for the first time a modulation in spinal loop properties after prolonged running.

Mesh:

Year:  2006        PMID: 17093121     DOI: 10.1152/jn.00903.2006

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  27 in total

1.  Modulation of exercise-induced spinal loop properties in response to oxygen availability.

Authors:  Thomas Rupp; Sébastien Racinais; Aurélien Bringard; Thomas Lapole; Stéphane Perrey
Journal:  Eur J Appl Physiol       Date:  2014-11-01       Impact factor: 3.078

2.  Alteration in neuromuscular function after a 5 km running time trial.

Authors:  O Girard; G P Millet; J-P Micallef; S Racinais
Journal:  Eur J Appl Physiol       Date:  2011-10-20       Impact factor: 3.078

3.  Neural and muscular adjustments following repeated running sprints.

Authors:  Stéphane Perrey; Sébastien Racinais; Khaled Saimouaa; Olivier Girard
Journal:  Eur J Appl Physiol       Date:  2010-04-01       Impact factor: 3.078

4.  Does central fatigue exist under low-frequency stimulation of a low fatigue-resistant muscle?

Authors:  Maria Papaiordanidou; David Guiraud; Alain Varray
Journal:  Eur J Appl Physiol       Date:  2010-07-04       Impact factor: 3.078

5.  No effect of prior caffeine ingestion on neuromuscular recovery after maximal fatiguing contractions.

Authors:  Marius S Fimland; Jan Helgerud; Andreas Knutsen; Helge Ruth; Gunnar Leivseth; Jan Hoff
Journal:  Eur J Appl Physiol       Date:  2009-09-17       Impact factor: 3.078

6.  High temperature does not alter fatigability in intact mouse skeletal muscle fibres.

Authors:  Nicolas Place; Takashi Yamada; Shi-Jin Zhang; Håkan Westerblad; Joseph D Bruton
Journal:  J Physiol       Date:  2009-08-12       Impact factor: 5.182

Review 7.  Repeated-sprint ability - part I: factors contributing to fatigue.

Authors:  Olivier Girard; Alberto Mendez-Villanueva; David Bishop
Journal:  Sports Med       Date:  2011-08-01       Impact factor: 11.136

8.  Locomotor and diaphragm muscle fatigue in endurance athletes performing time-trials of different durations.

Authors:  Thomas U Wüthrich; Elisabeth C Eberle; Christina M Spengler
Journal:  Eur J Appl Physiol       Date:  2014-04-29       Impact factor: 3.078

Review 9.  Physiological differences between cycling and running: lessons from triathletes.

Authors:  Gregoire P Millet; V E Vleck; D J Bentley
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  Hyperthermia impairs short-term memory and peripheral motor drive transmission.

Authors:  S Racinais; N Gaoua; J Grantham
Journal:  J Physiol       Date:  2008-08-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.